Louis P. Lacasse
Presidente presso Centre For Commercialization of Cancer Immunotherapy
Provenienza dei contatti di primo grado di Louis P. Lacasse
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
The Caisse de dépôt et placement du Québec
 The Caisse de dépôt et placement du Québec Investment ManagersFinance The Caisse de dépôt et placement du Québec (CDPQ) is a government-owned institutional fund manager headquartered in Montréal, Canada. Founded in 1965, CDPQ manages the funds of several depositor groups primarily for public and parapublic pension and insurance plans which pay out benefits to more than two million Quebecers each year.
27
| Subsidiary | Investment Managers | 27 |
| Subsidiary | Biotechnology | 22 | |
21
| Extinct | Medical Specialties | 21 |
Advitech, Inc.
 Advitech, Inc. BiotechnologyHealth Technology Advitech Inc. is a health sciences and technology company, which develops, manufactures and marketes proprietary natural ingredients and formulations for oral and topical applications. Its products are based on three technological platforms: a superior multi-functional emulsification delivery system derived from plant seed oleosomes for formulation application in the topical cosmetic, OTC, Rx and natural personal care specialty ingredient markets, XP-828L for immune mediated inflammatory disorders and IM for anti-aging and wound healing. Advitech was founded in 1997 and is headquartered in Québec, Canada
14
| Extinct | Biotechnology | 14 |
| Extinct | Pharmaceuticals: Major | 12 | |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA.
12
| Extinct | Biotechnology | 12 |
Centre For Commercialization of Cancer Immunotherapy
 Centre For Commercialization of Cancer Immunotherapy Centre For Commercialization of Cancer Immunotherapy provides solution for the development, translation, and commercialization of cancer immunotherapy and regenerative medicine. It offers clinical research unit, contract research organization, and innovation and commercialization unit services. The company was founded by Lambert Busque, Denis-Claude Roy and is headquartered in Montréal, Canada.
12
| Private Company | 12 | |
| Public Company | Packaged Software | 11 | |
Aegera Therapeutics, Inc.
 Aegera Therapeutics, Inc. BiotechnologyHealth Technology Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.
11
| Subsidiary | Biotechnology | 11 |
Bellus Health (Innodia), Inc.
 Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
GeneChem Management, Inc.
 GeneChem Management, Inc. Investment ManagersFinance GeneChem Management Inc (GeneChem) is an independent venture capital firm founded in 1997. The firm is headquartered in Montréal.
6
| Private Company | Investment Managers | 6 |
CDP Capital Private Equity
 CDP Capital Private Equity Investment ManagersFinance CDP Capital Private Equity (CDPQ) is a private equity subsidiary of The Caisse de dépôt et placement du Québec founded in 1995. The firm is headquartered in Montréal with additional office in London.
4
| Subsidiary | Investment Managers | 4 |
| Public Company | Regional Banks | 4 | |
AgeChem Financial, Inc.
 AgeChem Financial, Inc. Financial ConglomeratesFinance AgeChem Financial, Inc. engages in the provision of investment services, It seeks to invest in companies developing therapeutics targeting age-related diseases. The company was founded in 2006 and is headquartered in Montreal, Canada.
3
| Subsidiary | Financial Conglomerates | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Louis P. Lacasse tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | President Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
CIBC Asset Management, Inc.
 CIBC Asset Management, Inc. Investment ManagersFinance CIBC Asset Management, Inc. (CIBC AM) is a Canadian asset management firm headquartered in Toronto, Ontario. The firm was founded in 1972 and is a wholly owned subsidiary of the Canadian Imperial Bank of Commerce (NYSE, TSE: CM), a publicly traded Canadian chartered bank. CIBC AM manages assets on behalf of institutional, high-net-worth clients and underlying investors in their retail sponsored products. | Investment Managers | Head-Equity Investments Head-Equity Investments Director of Research - Equity | |
Fondaction Le Fonds De Développement De La Csn Pour La Co.
 Fondaction Le Fonds De Développement De La Csn Pour La Co. Investment ManagersFinance Fondaction Le Fonds De Développement De La Csn Pour La Co(Fondaction) is an independent venture capital firm founded in 1996.The firm is headquartered in Montreal, Canada. | Investment Managers | Corporate Secretary Private Equity Investor | |
| BELLUS HEALTH | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer General Counsel | |
| PALADIN LABS INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Medical Specialties | Chairman Director/Board Member Corporate Officer/Principal | |
| ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member | |
| ACASTI PHARMA INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Aztech Innovations, Inc.
 Aztech Innovations, Inc. Electrical ProductsProducer Manufacturing Aztech Innovations, Inc. is engaged in the sale of embedded systems, wireless remote monitoring and demand management products and related services. It was founded on March 7, 2007 and is headquartered in Kingston, Canada. | Electrical Products | Chairman Director/Board Member | |
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Corporate Officer/Principal Private Equity Investor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Cambridge | College/University | Undergraduate Degree Graduate Degree Doctorate Degree | |
| McGill University | College/University | Undergraduate Degree Masters Business Admin Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Concordia University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| University of Ottawa | College/University | Undergraduate Degree Graduate Degree Masters Business Admin Doctorate Degree Graduate Degree Masters Business Admin | |
| University of Guelph | College/University | Doctorate Degree Undergraduate Degree | |
| University of Toronto | College/University | Doctorate Degree Doctorate Degree | |
| University of Western Ontario | College/University | Doctorate Degree Masters Business Admin | |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Digi-Key Corp. distributes electronic components. It also distributes semiconductors, discrete, electromechanical parts. Its products include audio products, batteries, cable assemblies, capacitors, computer & video accessories, connectors, crystals & oscillators, discrete semiconductor products and many more. The company was founded by Ronald A. Stordahl in 1972 and is headquartered in Thief River Falls, MN. | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
| University of Montréal | College/University | Undergraduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree | |
PainCeptor Pharma Corp.
 PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Agrisoma Biosciences, Inc.
 Agrisoma Biosciences, Inc. Chemicals: SpecialtyProcess Industries Agrisoma Biosciences, Inc. provides crop technology for biofuel and renewable energy solutions. Its crop improvement technologies include proprietary breeding, proprietary tissue culture and haploidy, molecular markers and genetic mapping and advanced crop improvement technologies. The company was founded by Steven Fabijanski and Tom Mamic in 2001 and is headquartered in Gatineau, Canada. | Chemicals: Specialty | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| University of Sherbrooke | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Masters Business Admin Masters Business Admin | |
CDP Capital-Financing, Inc.
 CDP Capital-Financing, Inc. Financial ConglomeratesFinance CDP Capital-Financing, Inc. provides financing and investment services. The company is based in Montréal, Canada. The Canadian company is ultimately controlled by the Province of Québec. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Quebec | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Viron Therapeutics, Inc.
 Viron Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Université Laval | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
| HEC Montréal | College/University | Masters Business Admin Graduate Degree Masters Business Admin Undergraduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree | |
| NEVRO CORP. | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
Neurochem (International) Ltd.
 Neurochem (International) Ltd. Miscellaneous Commercial ServicesCommercial Services Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland. | Miscellaneous Commercial Services | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel | |
Natunola AgriTech, Inc.
 Natunola AgriTech, Inc. Pharmaceuticals: OtherHealth Technology Natunola AgriTech, Inc. develops, manufactures and markets proprietary natural ingredients. It offers ingredients to the personal care, food and nutraceutical markets. The company was founded on June 30, 2004 and is headquartered in Winchester, Canada. | Pharmaceuticals: Other | President President | |
AmorChem Financial, Inc.
 AmorChem Financial, Inc. Financial ConglomeratesFinance AmorChem Financial, Inc. provides financial investment services. The company is headquartered in Westmount, Canada. | Financial Conglomerates | Director/Board Member Chairman Founder | |
Insitut de Recherche en Immunologie et en Cancérologie
 Insitut de Recherche en Immunologie et en Cancérologie Miscellaneous Commercial ServicesCommercial Services Insitut de Recherche en Immunologie et en Cancérologie develops and discovers treatment and therapies for cancers. It also engages in anticancer drug discovery chain. The company was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Chairman Chief Executive Officer | |
| Harvard Business School | College/University | Graduate Degree Masters Business Admin | |
SpecificiT Pharma, Inc.
 SpecificiT Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services SpecificiT Pharma, Inc. develops personalized cancer immunotherapies. The company is headquartered in Westmount, Canada. | Miscellaneous Commercial Services | Director/Board Member Founder | |
ARTMS, Inc.
 ARTMS, Inc. BiotechnologyHealth Technology ARTMS, Inc. operates as biotechnology company, which develops novel technology and products. The company was founded by Michael Cross and is headquartered in Burnaby, Canada. | Biotechnology | Founder Director/Board Member | |
Nimbus Synergies, Inc.
 Nimbus Synergies, Inc. Investment ManagersFinance Nimbus Synergies Inc (Nimbus Synergies) is a venture capital firm founded in 2017 by Jason Robertson. The firm is headquartered in British Columbia, Canada. | Investment Managers | Director/Board Member Director/Board Member |
Statistiche
Distribuzione geografica
| Canada | 37 |
| Stati Uniti | 12 |
| Regno Unito | 2 |
| Francia | 2 |
| Svizzera | 2 |
Settori
| Health Technology | 19 |
| Consumer Services | 17 |
| Finance | 9 |
| Commercial Services | 6 |
| Producer Manufacturing | 2 |
Posizioni
| Director/Board Member | 431 |
| Corporate Officer/Principal | 158 |
| Independent Dir/Board Member | 95 |
| President | 84 |
| Chairman | 70 |
Contatti più connessi
| Insiders | |
|---|---|
| Peter Thompson | 39 |
| Paul Klingenstein | 34 |
| Darrell J. Elliott | 29 |
| Dan Kisner | 29 |
| Michael Perry | 28 |
| Francesco Bellini | 27 |
| Jim Scopa | 26 |
| Margaret Mulligan | 21 |
| Martin Godbout | 21 |
| Richard O'Connor Whittall | 20 |
| Luc Reny | 18 |
| Pierre Comtois | 18 |
| Marc-Andre Lebel | 18 |
| Aki Georgacacos | 17 |
| Joe Regan | 17 |
- Borsa valori
- Insiders
- Louis P. Lacasse
- Connessioni Società
